07/02/2026
Heart failure is a complex clinical syndrome affecting around 70 million individuals globally. Approximately half of all cases are attributed to reduced left ventricular systolic function—classified as heart failure with reduced ejection fraction (HFrEF).
A new Seminar provides an overview of the current diagnostic and pharmacological management of patients with HFrEF, highlighting the progress and outlining the challenges that remain.
Access the full paper via the link in comments 💬
📊 Figure: Pragmatic approach to the diagnosis and treatment of heart failure with reduced ejection fraction and heart failure with mildly reduced ejection fraction.